Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6376511 | 0.98 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL3344028 | 0.93 | — | — | |
| SCHEMBL3349558 | 0.80 | NAAA (0.33) | EPHX1 | |
| SCHEMBL6178787 | 0.76 | — | — | |
| SCHEMBL6178352 | 0.76 | CA1 (0.32) | — | |
| SCHEMBL6181352 | 0.73 | CA1 (0.36) | EPHX1 | |
| SCHEMBL3349536 | 0.73 | SMN1; SMN2 (0.36) | — | |
| SCHEMBL2582250 | 0.72 | — | — | |
| SCHEMBL765983 | 0.70 | EPHX1 (0.38) | EPHX1 | |
| SCHEMBL6383370 | 0.70 | EPHX1 (0.38) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140024527-A1 | HERBICIDAL PYRAZINONES | E I DU DE NEMOURS AND COMPANY (US) | 2014-01-23 | — | — | US | disclosed |
| WO-2012148622-A1 | HERBICIDAL PYRAZINONES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-01 | — | — | WO | disclosed |
| CN-101466688-A | Oxazole derivatives and their use in the treatment of diabetes and obesity | ASTRAZENECA AB (SE) | 2009-06-24 | — | — | CN | disclosed |
| CN-101115731-A | Oxadiazole derivatives as DGAT inhibitors | ASTRAZENECA AB (SE) | 2008-01-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140024527-A1 | HERBICIDAL PYRAZINONES | CYP1B1, CBR3, CYP1A1 | EPHX1 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.